Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status

Revill PA, Tu T, Netter HJ, et al. The evolution and clinical impact of hepatitis B virus genome diversity. Nat Rev Gastroenterol Hepatol. 2020;17(10):618–634

Article  Google Scholar 

Yuen MF, Chen DS, Dusheiko GM, et al. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035

Article  Google Scholar 

Liu J, Liang W, Jing W, et al. Countdown to 2030: eliminating hepatitis B disease. China Bull World Health Organ. 2019;97(3):230–238

Article  Google Scholar 

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.

World Orgnization Health. Hepatitis B. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b [cited 31 Dec 2021].

Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Available from: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ [cited 31 Dec 2021].

Global health sector strategy on viral hepatitis 2016–2021. Geneva: World Health Organization; 2016. Available from: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ [cited 31 Dec 2021]

Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5):S13-21

CAS  Article  Google Scholar 

Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346(22):1682–1683

Article  Google Scholar 

Organization WH. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. http://apps.who.int/iris/bitstream/handle/10665/154590/9789241549059_eng.pdf;jsessionid=C45FBB6C849F7F96F2213274A3FE2336?sequence=1. Accessed Mar 2015, 2015.

Tian Y, Kuo CF, Akbari O, et al. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44(5):1204–1214

CAS  Article  Google Scholar 

Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59(1):89–97

CAS  Article  Google Scholar 

Zeng DY, Li JM, Lin S, et al. Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. J Hepatol. 2021;75(3):547–556

Article  Google Scholar 

Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–683

Article  Google Scholar 

Haberl EM, Feder S, Pohl R, et al. Chemerin is induced in non-alcoholic fatty liver disease and hepatitis B-related hepatocellular carcinoma. Cancers (Basel). 2020;12(10):2967

CAS  Article  Google Scholar 

GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245–266.

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) UHC Effective Coverage Index 1990–2019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020. https://doi.org/10.6069/GT4K-3B35.

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1250–1284.

WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. 2021; https://www.who.int/publications/i/item/9789240027077 [cited 12 July 2022].

Hepatitis B. vaccines: WHO position paper–recommendations. Vaccine. 2010;28(3):589–590

Article  Google Scholar 

World Health Organization. Immunization coverage. Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage [cited 12 July 2022].

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet. 2021;398(10299):503–521.

Lesi OA, Ward JW. Paving the way towards hepatitis B virus-free generations in Africa. Lancet Glob Health. 2021;9(11):e1491–e1492

Article  Google Scholar 

Hepatitis B. vaccines: WHO position paper—July 2017. Wkly Epidemiol Rec. 2017;92(27):369–392

Google Scholar 

World Health Organization. Practices to improve coverage of the hepatitis B birth dose vaccine, 2013. Geneva, 2013. Available at http://www.who.int/immunization/documents/control/who_ivb_12.11/en/. [cited 10 July 2022].

Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol. 2016;13(11):643–653

Article  Google Scholar 

WHO. Hepatitis B control: country profile 2020. 2021; https://www.who.int/publications/i/item/9789290616986 [cited 12 July 2022].

Shiffman ML. Management of acute hepatitis B. Clin Liver Dis. 2010;14(1):75–91

Article  Google Scholar 

Perrillo RP, Strang S, Lowry OH. Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally disabled. Am J Epidemiol. 1986;123(4):690–698

CAS  Article  Google Scholar 

Razavi-Shearer D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403

Article  Google Scholar 

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022.

Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582–592

CAS  Article  Google Scholar 

Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604

Article  Google Scholar 

Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555

Article  Google Scholar 

NHS. Hepatitis B vaccine. https://www.nhs.uk/conditions/vaccinations/hepatitis-b-vaccine/?tabname=babies-and-toddlers. Accessed 13 Jan 2019.

Krahn M, Detsky AS. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Med Decis Making. 1993;13(1):4–20

CAS  Article  Google Scholar 

Trépo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020;72(6):1196–1209

Article  Google Scholar 

Paik JM, Golabi P, Younossi Y, et al. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72(5):1605–1616

Article  Google Scholar 

Carrion AF, Martin P. Viral hepatitis in the elderly. Am J Gastroenterol. 2012;107(5):691–697

Article  Google Scholar 

Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155–2166

Article  Google Scholar 

Yang JD, Gyedu A, Afihene MY, et al. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol. 2015;110(11):1629–1631

CAS  Article  Google Scholar 

Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6

Article  Google Scholar 

Pol S, Haour G, Fontaine H, et al. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017;46(11–12):1054–1060

CAS  Article  Google Scholar 

Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009;48(12):1763–1771

Article  Google Scholar 

留言 (0)

沒有登入
gif